Home•Our Research•Publications•Disease-Modifying Treatments for Multiple Sclerosis Affect Measures of Cellular Immune Responses to EBNA-1 Peptides

Disease-Modifying Treatments for Multiple Sclerosis Affect Measures of Cellular Immune Responses to EBNA-1 Peptides

Thematic Area:
Therapeutics
Disease Area:
Multiple Sclerosis
Research Focus:
BiomarkersHealth Data Analytics
Collaborators:
AcademicClinical